GlassScriptPhysician profile
Peter R Boshara
NPI 1659858942
$6,867.05
in general payments reported to CMS, 2019-2025
14 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,332 · 2023: $231 · 2024: $3,800 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,971 · Food and Beverage: $1,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,971.05 |
| Food and Beverage | $1,564.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,001.67 | 2022 | |
| Intuitive Surgical, INC. | $1,090.20 | 2024 | |
| Olympus Corporation of The Americas | $917.88 | 2024 | Single Use Suction Valve (Sterile), Vizishot 2 Flex |
| Medical Device Business Services, INC. | $830.39 | 2024 | Monarch, Monarch Platform |
| Pinnacle Biologics, INC | $668.51 | 2024 | Photofrin |
| Pulmonx Corporation | $546.40 | 2022-2025 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| Becton, Dickinson and Company | $203.01 | 2024 | Powerpicc |
| Olympus America INC. | $128.44 | 2024-2025 | Single-Use Flexible Video Bronchoscope |
| Astrazeneca Pharmaceuticals LP | $109.80 | 2022 | |
| Glaxosmithkline, LLC. | $99.29 | 2023 | Nucala |
| Viatris Specialty LLC | $85.69 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.68 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.52 | 2023 | Glassia |
| Ethicon INC. | $30.57 | 2024 | Monarch Platform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Boshara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.